var eventsData = [{"Ticker":"BAC","EffectiveDate":"2017-01-13","Type":"EarningsBeatRevenueMiss","Title":"Before market open, BAC reports 2016 Q4's earning $0.4 per share and revenue $20224MM. This beats analyst's estimated EPS $0.38, misses estimated revenue $20990MM.","DailyReturn":"0.39%","FiveDayReturnAfter":"-1.22%","FiveDayReturnBefore":"1.05%"},{"Ticker":"BAC","EffectiveDate":"2017-01-12","Type":"RatingUpgrade","Title":"Societe Generale upgrades BAC to Buy from Hold. Target Price is $31.5; previously $17.","DailyReturn":"-0.65%","FiveDayReturnAfter":"-2.36%","FiveDayReturnBefore":"0.52%"},{"Ticker":"BAC","EffectiveDate":"2017-01-11","Type":"RatingNeutral","Title":"UBS downgrades BAC to Neutral from Buy. Target Price is $23; previously $24.","DailyReturn":"0.56%","FiveDayReturnAfter":"-1.36%","FiveDayReturnBefore":"1.8%"},{"Ticker":"BAC","EffectiveDate":"2016-12-21","Type":"RatingUpgrade","Title":"Atlantic Equities upgrades BAC to Overweight from Neutral.","DailyReturn":"-0.35%","FiveDayReturnAfter":"-1.68%","FiveDayReturnBefore":"0.44%"},{"Ticker":"BAC","EffectiveDate":"2016-12-01","Type":"RatingNeutral","Title":"Standpoint Research downgrades BAC to Hold from Buy.","DailyReturn":"1.79%","FiveDayReturnAfter":"6.64%","FiveDayReturnBefore":"4.33%"},{"Ticker":"BAC","EffectiveDate":"2016-11-30","Type":"RatingNeutral","Title":"Deutsche Bank maintains BAC to Hold. Target Price is $23; previously $17.5.","DailyReturn":"4.47%","FiveDayReturnAfter":"9.18%","FiveDayReturnBefore":"-0.19%"},{"Ticker":"BAC","EffectiveDate":"2016-11-30","Type":"Dividend","Title":"The Firm pays dividend $0.075","DailyReturn":"4.47%","FiveDayReturnAfter":"9.18%","FiveDayReturnBefore":"-0.19%"},{"Ticker":"BAC","EffectiveDate":"2016-11-29","Type":"RatingUpgrade","Title":"Keefe Bruyette & Woods upgrades BAC to Outperform from Market Perform.","DailyReturn":"-0.04%","FiveDayReturnAfter":"7.68%","FiveDayReturnBefore":"1.48%"},{"Ticker":"BAC","EffectiveDate":"2016-11-16","Type":"RatingNeutral","Title":"Baird downgrades BAC to Neutral from Outperform.","DailyReturn":"-2.03%","FiveDayReturnAfter":"0.69%","FiveDayReturnBefore":"17.04%"},{"Ticker":"BAC","EffectiveDate":"2016-11-15","Type":"RatingNeutral","Title":"Guggenheim downgrades BAC to Neutral from Buy.","DailyReturn":"0.39%","FiveDayReturnAfter":"1.23%","FiveDayReturnBefore":"16.59%"},{"Ticker":"BAC","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Deutsche Bank downgrades BAC to Hold from Buy.","DailyReturn":"-0.05%","FiveDayReturnAfter":"16.59%","FiveDayReturnBefore":"3.04%"},{"Ticker":"BAC","EffectiveDate":"2016-10-17","Type":"EarningsRevenueBeat","Title":"Before market open, BAC reports 2016 Q3's earning $0.41 per share and revenue $21863MM. This beats analyst's estimated EPS $0.33, beats estimated revenue $20940MM.","DailyReturn":"0.31%","FiveDayReturnAfter":"4.1%","FiveDayReturnBefore":"-0.8%"},{"Ticker":"BAC","EffectiveDate":"2016-10-11","Type":"RatingNeutral","Title":"Compass Point initiates coverage on BAC to Neutral.","DailyReturn":"-1.16%","FiveDayReturnAfter":"-1.54%","FiveDayReturnBefore":"4.19%"},{"Ticker":"BAC","EffectiveDate":"2016-10-10","Type":"RatingNeutral","Title":"Jefferies maintains BAC to Buy.","DailyReturn":"1.05%","FiveDayReturnAfter":"-0.8%","FiveDayReturnBefore":"3.02%"},{"Ticker":"BAC","EffectiveDate":"2016-09-23","Type":"RatingNeutral","Title":"CLSA maintains BAC to Outperform. Target Price is $18; previously $17.","DailyReturn":"-0.51%","FiveDayReturnAfter":"-2.86%","FiveDayReturnBefore":"-0.44%"},{"Ticker":"BAC","EffectiveDate":"2016-08-31","Type":"Dividend","Title":"The Firm pays dividend $0.075","DailyReturn":"0.15%","FiveDayReturnAfter":"-2.6%","FiveDayReturnBefore":"5.32%"},{"Ticker":"BAC","EffectiveDate":"2016-07-19","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods maintains BAC to Market Perform. Target Price is $15; previously $14.","DailyReturn":"1.06%","FiveDayReturnAfter":"1.82%","FiveDayReturnBefore":"6.59%"},{"Ticker":"BAC","EffectiveDate":"2016-07-19","Type":"RatingNeutral","Title":"Citigroup maintains BAC to Buy. Target Price is $17; previously $16.","DailyReturn":"1.06%","FiveDayReturnAfter":"1.82%","FiveDayReturnBefore":"6.59%"},{"Ticker":"BAC","EffectiveDate":"2016-07-18","Type":"EarningsRevenueBeat","Title":"Before market open, BAC reports 2016 Q2's earning $0.36 per share and revenue $20621MM. This beats analyst's estimated EPS $0.33, beats estimated revenue $20520MM.","DailyReturn":"3.29%","FiveDayReturnAfter":"5.13%","FiveDayReturnBefore":"3.65%"},{"Ticker":"BAC","EffectiveDate":"2016-07-13","Type":"RatingNeutral","Title":"Berenberg initiates coverage on BAC to Buy. Target Price is $15.","DailyReturn":"-0.73%","FiveDayReturnAfter":"5.18%","FiveDayReturnBefore":"6.09%"},{"Ticker":"BAC","EffectiveDate":"2016-07-07","Type":"RatingNeutral","Title":"Raymond James downgrades BAC to Market Perform from Outperform.","DailyReturn":"1.16%","FiveDayReturnAfter":"4.41%","FiveDayReturnBefore":"1.25%"},{"Ticker":"BAC","EffectiveDate":"2016-06-01","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":"0.81%","FiveDayReturnAfter":"-2.68%","FiveDayReturnBefore":"2.18%"},{"Ticker":"BAC","EffectiveDate":"2016-05-16","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods downgrades BAC to Market Perform from Outperform. Target Price is $16; previously $17.","DailyReturn":"0.36%","FiveDayReturnAfter":"4.5%","FiveDayReturnBefore":"-1.64%"},{"Ticker":"BAC","EffectiveDate":"2016-04-14","Type":"RevenueBeat","Title":"Before market open, BAC reports 2016 Q1's earning $0.21 per share and revenue $19727MM. This meets analyst's estimated EPS $0.21, misses estimated revenue $20300MM.","DailyReturn":"2.53%","FiveDayReturnAfter":"7.94%","FiveDayReturnBefore":"3.84%"},{"Ticker":"BAC","EffectiveDate":"2016-04-07","Type":"RatingNeutral","Title":"JP Morgan maintains BAC to Overweight. Target Price is $16; previously $16.5.","DailyReturn":"-3.16%","FiveDayReturnAfter":"3.84%","FiveDayReturnBefore":"-1.57%"},{"Ticker":"BAC","EffectiveDate":"2016-03-10","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods maintains BAC to Outperform. Target Price is $19; previously $17.","DailyReturn":"0.98%","FiveDayReturnAfter":"1.28%","FiveDayReturnBefore":"-2.03%"},{"Ticker":"BAC","EffectiveDate":"2016-03-02","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":"2.05%","FiveDayReturnAfter":"-0.61%","FiveDayReturnBefore":"8.13%"},{"Ticker":"BAC","EffectiveDate":"2016-03-01","Type":"RatingNeutral","Title":"Atlantic Equities downgrades BAC to Neutral from Overweight.","DailyReturn":"5.35%","FiveDayReturnAfter":"8.13%","FiveDayReturnBefore":"-0.15%"},{"Ticker":"BAC","EffectiveDate":"2016-02-25","Type":"RatingNeutral","Title":"Credit Suisse maintains BAC to Outperform. Target Price is $18; previously $20.","DailyReturn":"1.56%","FiveDayReturnAfter":"10.41%","FiveDayReturnBefore":"-3.48%"},{"Ticker":"BAC","EffectiveDate":"2016-01-29","Type":"RatingUpgrade","Title":"CLSA upgrades BAC to Outperform.","DailyReturn":"4.5%","FiveDayReturnAfter":"-2.09%","FiveDayReturnBefore":"1.26%"},{"Ticker":"BAC","EffectiveDate":"2016-01-26","Type":"RatingNeutral","Title":"Deutsche Bank maintains BAC to Buy. Target Price is $17; previously $19.","DailyReturn":"2.7%","FiveDayReturnAfter":"7.43%","FiveDayReturnBefore":"-10.95%"},{"Ticker":"BAC","EffectiveDate":"2016-01-20","Type":"RatingNeutral","Title":"Barclays maintains BAC to Equal-Weight. Target Price is $19; previously $20.","DailyReturn":"-3.86%","FiveDayReturnAfter":"-6.75%","FiveDayReturnBefore":"-7.24%"},{"Ticker":"BAC","EffectiveDate":"2016-01-20","Type":"RatingUpgrade","Title":"Sandler O'Neill upgrades BAC to Buy from Hold.","DailyReturn":"-3.86%","FiveDayReturnAfter":"-6.75%","FiveDayReturnBefore":"-7.24%"},{"Ticker":"BAC","EffectiveDate":"2016-01-19","Type":"EarningsBeatRevenueMiss","Title":"Before market open, BAC reports 2015 Q4's earning $0.28 per share and revenue $19759MM. This beats analyst's estimated EPS $0.27, misses estimated revenue $20120MM.","DailyReturn":"-1.52%","FiveDayReturnAfter":"-10.95%","FiveDayReturnBefore":"-4.99%"},{"Ticker":"BAC","EffectiveDate":"2015-12-02","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":"-0.78%","FiveDayReturnAfter":"-3.26%","FiveDayReturnBefore":"1.92%"},{"Ticker":"BAC","EffectiveDate":"2015-10-07","Type":"RatingNeutral","Title":"Jefferies maintains BAC to Buy. Target Price is $18; previously $21.","DailyReturn":"0.38%","FiveDayReturnAfter":"-1.08%","FiveDayReturnBefore":"2.19%"},{"Ticker":"BAC","EffectiveDate":"2015-10-06","Type":"RatingNeutral","Title":"Oppenheimer maintains BAC to Outperform. Target Price is $19; previously $21.","DailyReturn":"0%","FiveDayReturnAfter":"-1.08%","FiveDayReturnBefore":"1.41%"},{"Ticker":"BAC","EffectiveDate":"2015-09-08","Type":"RatingUpgrade","Title":"Nomura upgrades BAC to Buy from Neutral.","DailyReturn":"3.25%","FiveDayReturnAfter":"1.96%","FiveDayReturnBefore":"-4.11%"},{"Ticker":"BAC","EffectiveDate":"2015-09-02","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":"2.06%","FiveDayReturnAfter":"2.35%","FiveDayReturnBefore":"2.07%"},{"Ticker":"BAC","EffectiveDate":"2015-08-26","Type":"RatingUpgrade","Title":"UBS upgrades BAC to Buy from Neutral. Target Price is $20; previously $18.","DailyReturn":"5.24%","FiveDayReturnAfter":"2.07%","FiveDayReturnBefore":"-14.77%"},{"Ticker":"BAC","EffectiveDate":"2015-08-25","Type":"RatingUpgrade","Title":"Bernstein upgrades BAC to Outperform from Neutral. Target Price is $19.","DailyReturn":"-0.19%","FiveDayReturnAfter":"6.64%","FiveDayReturnBefore":"-15.03%"},{"Ticker":"BAC","EffectiveDate":"2015-08-25","Type":"RatingUpgrade","Title":"Baird upgrades BAC to Outperform from Neutral.","DailyReturn":"-0.19%","FiveDayReturnAfter":"6.64%","FiveDayReturnBefore":"-15.03%"},{"Ticker":"BAC","EffectiveDate":"2015-08-25","Type":"RatingUpgrade","Title":"Macquarie upgrades BAC to Neutral from Underperform.","DailyReturn":"-0.19%","FiveDayReturnAfter":"6.64%","FiveDayReturnBefore":"-15.03%"},{"Ticker":"BAC","EffectiveDate":"2015-08-24","Type":"RatingUpgrade","Title":"Keefe Bruyette & Woods upgrades BAC to Outperform from Market Perform. Target Price is $20.","DailyReturn":"-5.03%","FiveDayReturnAfter":"1.6%","FiveDayReturnBefore":"-9.47%"},{"Ticker":"BAC","EffectiveDate":"2015-07-20","Type":"RatingNeutral","Title":"Jefferies maintains BAC to Buy. Target Price is $21.","DailyReturn":"0.11%","FiveDayReturnAfter":"-1.11%","FiveDayReturnBefore":"8.05%"},{"Ticker":"BAC","EffectiveDate":"2015-07-20","Type":"RatingNeutral","Title":"RBC Capital maintains BAC to Outperform. Target Price is $20; previously $19.","DailyReturn":"0.11%","FiveDayReturnAfter":"-1.11%","FiveDayReturnBefore":"8.05%"},{"Ticker":"BAC","EffectiveDate":"2015-07-16","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods maintains BAC to Market Perform. Target Price is $20; previously $17.","DailyReturn":"1.52%","FiveDayReturnAfter":"4.26%","FiveDayReturnBefore":"8.43%"},{"Ticker":"BAC","EffectiveDate":"2015-07-15","Type":"EarningsRevenueBeat","Title":"Before market open, BAC reports 2015 Q2's earning $0.45 per share and revenue $22345MM. This beats analyst's estimated EPS $0.36, beats estimated revenue $21300MM.","DailyReturn":"3.21%","FiveDayReturnAfter":"5.39%","FiveDayReturnBefore":"2.6%"},{"Ticker":"BAC","EffectiveDate":"2015-06-03","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":"1.55%","FiveDayReturnAfter":"3.76%","FiveDayReturnBefore":"1.32%"},{"Ticker":"BAC","EffectiveDate":"2015-05-28","Type":"RatingNeutral","Title":"Portales Partners downgrades BAC to Sector Perform from Outperform.","DailyReturn":"-0.41%","FiveDayReturnAfter":"1.42%","FiveDayReturnBefore":"-0.17%"},{"Ticker":"BAC","EffectiveDate":"2015-05-06","Type":"RatingNeutral","Title":"BMO Capital downgrades BAC to Market Perform from Outperform.","DailyReturn":"-0.36%","FiveDayReturnAfter":"0.48%","FiveDayReturnBefore":"4.37%"},{"Ticker":"BAC","EffectiveDate":"2015-04-16","Type":"RatingNeutral","Title":"Oppenheimer maintains BAC to Outperform. Target Price is $21; previously $22.","DailyReturn":"0.95%","FiveDayReturnAfter":"0.63%","FiveDayReturnBefore":"0.19%"},{"Ticker":"BAC","EffectiveDate":"2015-04-16","Type":"RatingNeutral","Title":"Barclays maintains BAC to Equal-Weight. Target Price is $19; previously $20.","DailyReturn":"0.95%","FiveDayReturnAfter":"0.63%","FiveDayReturnBefore":"0.19%"},{"Ticker":"BAC","EffectiveDate":"2015-04-16","Type":"RatingNeutral","Title":"Jefferies maintains BAC to Buy. Target Price is $18; previously $19.","DailyReturn":"0.95%","FiveDayReturnAfter":"0.63%","FiveDayReturnBefore":"0.19%"},{"Ticker":"BAC","EffectiveDate":"2015-04-16","Type":"RatingNeutral","Title":"BMO Capital maintains BAC to Outperform. Target Price is $18; previously $19.","DailyReturn":"0.95%","FiveDayReturnAfter":"0.63%","FiveDayReturnBefore":"0.19%"},{"Ticker":"BAC","EffectiveDate":"2015-04-15","Type":"EarningsRevenueMiss","Title":"Before market open, BAC reports 2015 Q1's earning $0.27 per share and revenue $21202MM. This misses analyst's estimated EPS $0.3, misses estimated revenue $21640MM.","DailyReturn":"-1.13%","FiveDayReturnAfter":"-2.04%","FiveDayReturnBefore":"2.3%"},{"Ticker":"BAC","EffectiveDate":"2015-03-17","Type":"RatingNeutral","Title":"Raymond James assumes BAC to Outperform. Target Price is $18.","DailyReturn":"-0.24%","FiveDayReturnAfter":"-2.57%","FiveDayReturnBefore":"-0.24%"},{"Ticker":"BAC","EffectiveDate":"2015-03-13","Type":"RatingNeutral","Title":"Oppenheimer maintains BAC to Outperform. Target Price is $22; previously $21.","DailyReturn":"0%","FiveDayReturnAfter":"-3.02%","FiveDayReturnBefore":"0.56%"},{"Ticker":"BAC","EffectiveDate":"2015-03-04","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":"-0.93%","FiveDayReturnAfter":"-1.25%","FiveDayReturnBefore":"-2.09%"},{"Ticker":"BAC","EffectiveDate":"2015-03-02","Type":"RatingNeutral","Title":"Citigroup maintains BAC to Buy. Target Price is $18; previously $19.","DailyReturn":"1.26%","FiveDayReturnAfter":"2.87%","FiveDayReturnBefore":"-3.54%"},{"Ticker":"BAC","EffectiveDate":"2015-02-27","Type":"RatingNeutral","Title":"UBS downgrades BAC to Neutral from Buy.","DailyReturn":"-1.43%","FiveDayReturnAfter":"0.06%","FiveDayReturnBefore":"-1.05%"},{"Ticker":"BAC","EffectiveDate":"2015-01-16","Type":"RatingNeutral","Title":"Jefferies maintains BAC to Buy. Target Price is $19; previously $20.","DailyReturn":"1.18%","FiveDayReturnAfter":"3.42%","FiveDayReturnBefore":"-12.88%"},{"Ticker":"BAC","EffectiveDate":"2015-01-15","Type":"RevenueBeat","Title":"Before market open, BAC reports 2014 Q4's earning $0.32 per share and revenue $18725MM. This meets analyst's estimated EPS $0.32, misses estimated revenue $20940MM.","DailyReturn":"-5.23%","FiveDayReturnAfter":"0.31%","FiveDayReturnBefore":"-5.45%"},{"Ticker":"BAC","EffectiveDate":"2015-01-08","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on BAC to Overweight. Target Price is $21.","DailyReturn":"2.06%","FiveDayReturnAfter":"-5.45%","FiveDayReturnBefore":"-6.78%"},{"Ticker":"BAC","EffectiveDate":"2015-01-05","Type":"RatingNeutral","Title":"Barclays maintains BAC to Equal-Weight. Target Price is $20; previously $18.","DailyReturn":"-2.9%","FiveDayReturnAfter":"-5.27%","FiveDayReturnBefore":"-0.44%"},{"Ticker":"BAC","EffectiveDate":"2014-12-16","Type":"RatingNeutral","Title":"Guggenheim initiates coverage on BAC to Buy. Target Price is $20.","DailyReturn":"-0.77%","FiveDayReturnAfter":"4.97%","FiveDayReturnBefore":"-4.69%"},{"Ticker":"BAC","EffectiveDate":"2014-12-03","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":"1.11%","FiveDayReturnAfter":"2.65%","FiveDayReturnBefore":"-0.17%"},{"Ticker":"BAC","EffectiveDate":"2014-10-16","Type":"RatingUpgrade","Title":"FBR Capital upgrades BAC to Outperform from Market Perform. Target Price is $20; previously $18.","DailyReturn":"2.03%","FiveDayReturnAfter":"3.98%","FiveDayReturnBefore":"-8.27%"},{"Ticker":"BAC","EffectiveDate":"2014-10-02","Type":"RatingUpgrade","Title":"UBS upgrades BAC to Buy from Neutral.","DailyReturn":"0.35%","FiveDayReturnAfter":"1.76%","FiveDayReturnBefore":"-2.11%"},{"Ticker":"BAC","EffectiveDate":"2014-09-08","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades BAC to Buy from Neutral.","DailyReturn":"2.05%","FiveDayReturnAfter":"4.69%","FiveDayReturnBefore":"0.37%"},{"Ticker":"BAC","EffectiveDate":"2014-09-04","Type":"RatingNeutral","Title":"JP Morgan maintains BAC to Overweight. Target Price is $17.5; previously $17.","DailyReturn":"0.06%","FiveDayReturnAfter":"1.6%","FiveDayReturnBefore":"-1.11%"},{"Ticker":"BAC","EffectiveDate":"2014-09-03","Type":"RatingNeutral","Title":"Nomura downgrades BAC to Neutral from Buy.","DailyReturn":"-0.73%","FiveDayReturnAfter":"-0.49%","FiveDayReturnBefore":"-0.12%"},{"Ticker":"BAC","EffectiveDate":"2014-09-03","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":"-0.73%","FiveDayReturnAfter":"-0.49%","FiveDayReturnBefore":"-0.12%"},{"Ticker":"BAC","EffectiveDate":"2014-07-16","Type":"EarningsRevenueBeat","Title":"Before market open, BAC reports 2014 Q2's earning $0.41 per share and revenue $21960MM. This beats analyst's estimated EPS $0.3, beats estimated revenue $21710MM.","DailyReturn":"-1.89%","FiveDayReturnAfter":"-1.85%","FiveDayReturnBefore":"1.46%"},{"Ticker":"BAC","EffectiveDate":"2014-07-02","Type":"RatingUpgrade","Title":"Deutsche Bank upgrades BAC to Buy from Hold. Target Price is $18; previously $16.5.","DailyReturn":"1.6%","FiveDayReturnAfter":"0%","FiveDayReturnBefore":"0.7%"},{"Ticker":"BAC","EffectiveDate":"2014-06-20","Type":"Dividend","Title":"The Firm pays dividend $0.01","DailyReturn":"-0.57%","FiveDayReturnAfter":"-0.84%","FiveDayReturnBefore":"0.83%"},{"Ticker":"BAC","EffectiveDate":"2014-06-19","Type":"RatingNeutral","Title":"JP Morgan maintains BAC to Overweight. Target Price is $17; previously $17.5.","DailyReturn":"-0.63%","FiveDayReturnAfter":"-1.09%","FiveDayReturnBefore":"0.38%"},{"Ticker":"BAC","EffectiveDate":"2014-05-21","Type":"RatingNeutral","Title":"MKM Partners initiates coverage on BAC to Buy. Target Price is $18.","DailyReturn":"0.55%","FiveDayReturnAfter":"4.11%","FiveDayReturnBefore":"-3.38%"},{"Ticker":"BAC","EffectiveDate":"2014-05-12","Type":"RatingNeutral","Title":"Jefferies maintains BAC to Buy. Target Price is $18; previously $18.5.","DailyReturn":"2.23%","FiveDayReturnAfter":"-1.57%","FiveDayReturnBefore":"-3.4%"},{"Ticker":"BAC","EffectiveDate":"2014-05-12","Type":"RatingUpgrade","Title":"Portales Partners upgrades BAC to Sector Perform from Underperform.","DailyReturn":"2.23%","FiveDayReturnAfter":"-1.57%","FiveDayReturnBefore":"-3.4%"},{"Ticker":"BAC","EffectiveDate":"2014-04-29","Type":"RatingNeutral","Title":"JP Morgan maintains BAC to Overweight. Target Price is $17.5; previously $18.","DailyReturn":"1.93%","FiveDayReturnAfter":"0.86%","FiveDayReturnBefore":"-7.34%"},{"Ticker":"BAC","EffectiveDate":"2014-04-25","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains BAC to Neutral. Target Price is $17; previously $19.","DailyReturn":"-2.38%","FiveDayReturnAfter":"-7.95%","FiveDayReturnBefore":"1.29%"},{"Ticker":"BAC","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Deutsche Bank maintains BAC to Hold. Target Price is $16.5; previously $15.","DailyReturn":"-0.18%","FiveDayReturnAfter":"-7.81%","FiveDayReturnBefore":"-0.12%"},{"Ticker":"BAC","EffectiveDate":"2014-04-17","Type":"RatingUpgrade","Title":"Oppenheimer upgrades BAC to Outperform from market perform. Target Price is $19.","DailyReturn":"0.12%","FiveDayReturnAfter":"1.29%","FiveDayReturnBefore":"-2.99%"},{"Ticker":"BAC","EffectiveDate":"2014-04-17","Type":"RatingNeutral","Title":"Morgan Stanley maintains BAC to Overweight. Target Price is $20; previously $21.","DailyReturn":"0.12%","FiveDayReturnAfter":"1.29%","FiveDayReturnBefore":"-2.99%"},{"Ticker":"BAC","EffectiveDate":"2014-04-17","Type":"RatingNeutral","Title":"Jefferies maintains BAC to Buy. Target Price is $18.5; previously $20.","DailyReturn":"0.12%","FiveDayReturnAfter":"1.29%","FiveDayReturnBefore":"-2.99%"},{"Ticker":"BAC","EffectiveDate":"2014-03-24","Type":"RatingNeutral","Title":"Atlantic Equities downgrades BAC to Neutral from Overweight.","DailyReturn":"-1.08%","FiveDayReturnAfter":"-3.35%","FiveDayReturnBefore":"4.42%"},{"Ticker":"BAC","EffectiveDate":"2014-03-05","Type":"Dividend","Title":"The Firm pays dividend $0.01","DailyReturn":"3.16%","FiveDayReturnAfter":"3.23%","FiveDayReturnBefore":"2.35%"},{"Ticker":"BAC","EffectiveDate":"2014-01-16","Type":"RatingNeutral","Title":"Raymond James maintains BAC to Outperform. Target Price is $20; previously $17.","DailyReturn":"-0.4%","FiveDayReturnAfter":"-1.7%","FiveDayReturnBefore":"3.38%"},{"Ticker":"BAC","EffectiveDate":"2014-01-15","Type":"EarningsRevenueBeat","Title":"Before market open, BAC reports 2013 Q4's earning $0.29 per share and revenue $21490MM. This beats analyst's estimated EPS $0.27, beats estimated revenue $21280MM.","DailyReturn":"2.26%","FiveDayReturnAfter":"2.24%","FiveDayReturnBefore":"1.62%"},{"Ticker":"BAC","EffectiveDate":"2014-01-09","Type":"RatingNeutral","Title":"Nomura initiates coverage on BAC to Buy. Target Price is $19.","DailyReturn":"1.5%","FiveDayReturnAfter":"3.38%","FiveDayReturnBefore":"6.28%"},{"Ticker":"BAC","EffectiveDate":"2014-01-08","Type":"RatingNeutral","Title":"Jefferies initiates coverage on BAC to Buy. Target Price is $19.","DailyReturn":"0.48%","FiveDayReturnAfter":"1.62%","FiveDayReturnBefore":"5.99%"},{"Ticker":"BAC","EffectiveDate":"2014-01-02","Type":"RatingUpgrade","Title":"Citigroup upgrades BAC to Buy from Neutral. Target Price is $19; previously $16.","DailyReturn":"3.4%","FiveDayReturnAfter":"6.28%","FiveDayReturnBefore":"-0.76%"},{"Ticker":"BAC","EffectiveDate":"2013-12-04","Type":"Dividend","Title":"The Firm pays dividend $0.01","DailyReturn":"0.64%","FiveDayReturnAfter":"0.19%","FiveDayReturnBefore":"-1.72%"},{"Ticker":"BAC","EffectiveDate":"2013-12-03","Type":"RatingNeutral","Title":"Guggenheim maintains BAC to Neutral. Target Price is $17; previously $16.","DailyReturn":"-1.2%","FiveDayReturnAfter":"-0.89%","FiveDayReturnBefore":"0.57%"},{"Ticker":"BAC","EffectiveDate":"2013-11-05","Type":"RatingNeutral","Title":"Bernstein maintains BAC to Market Perform. Target Price is $15.","DailyReturn":"-0.78%","FiveDayReturnAfter":"2.53%","FiveDayReturnBefore":"-1.34%"},{"Ticker":"BAC","EffectiveDate":"2013-10-17","Type":"RatingNeutral","Title":"Baird maintains BAC to Neutral. Target Price is $15; previously $14.","DailyReturn":"0.68%","FiveDayReturnAfter":"-2.43%","FiveDayReturnBefore":"5.07%"},{"Ticker":"BAC","EffectiveDate":"2013-10-17","Type":"RatingNeutral","Title":"Raymond James downgrades BAC to Outperform from Strong Buy. Target Price is $16; previously $16.5.","DailyReturn":"0.68%","FiveDayReturnAfter":"-2.43%","FiveDayReturnBefore":"5.07%"},{"Ticker":"BAC","EffectiveDate":"2013-10-16","Type":"EarningsBeatRevenueMiss","Title":"Before market open, BAC reports 2013 Q3's earning $0.2 per share and revenue $21700MM. This beats analyst's estimated EPS $0.18, misses estimated revenue $22080MM.","DailyReturn":"2.24%","FiveDayReturnAfter":"1.94%","FiveDayReturnBefore":"3.93%"},{"Ticker":"BAC","EffectiveDate":"2013-09-27","Type":"RatingNeutral","Title":"Guggenheim downgrades BAC to Neutral from Buy.","DailyReturn":"-1.27%","FiveDayReturnAfter":"-0.56%","FiveDayReturnBefore":"-3.69%"},{"Ticker":"BAC","EffectiveDate":"2013-09-19","Type":"RatingNeutral","Title":"Societe Generale initiates coverage on BAC to Buy. Target Price is $17.","DailyReturn":"-0.67%","FiveDayReturnAfter":"-3.95%","FiveDayReturnBefore":"0.4%"},{"Ticker":"BAC","EffectiveDate":"2013-09-04","Type":"Dividend","Title":"The Firm pays dividend $0.01","DailyReturn":"0.56%","FiveDayReturnAfter":"2.56%","FiveDayReturnBefore":"-1.67%"},{"Ticker":"BAC","EffectiveDate":"2013-08-21","Type":"RatingNeutral","Title":"Credit Suisse maintains BAC to Neutral. Target Price is $14; previously $13.","DailyReturn":"0.34%","FiveDayReturnAfter":"-1.26%","FiveDayReturnBefore":"-1.52%"},{"Ticker":"BAC","EffectiveDate":"2013-07-17","Type":"EarningsRevenueBeat","Title":"Before market open, BAC reports 2013 Q2's earning $0.32 per share and revenue $22900MM. This beats analyst's estimated EPS $0.25, beats estimated revenue $22790MM.","DailyReturn":"2.8%","FiveDayReturnAfter":"7.07%","FiveDayReturnBefore":"2.84%"},{"Ticker":"BAC","EffectiveDate":"2013-07-10","Type":"RatingNeutral","Title":"JP Morgan maintains BAC to Overweight. Target Price is $14.5; previously $13.5.","DailyReturn":"-1.18%","FiveDayReturnAfter":"2.84%","FiveDayReturnBefore":"4.53%"},{"Ticker":"BAC","EffectiveDate":"2013-06-07","Type":"RatingNeutral","Title":"Macquarie initiates coverage on BAC to Underperform. Target Price is $12.","DailyReturn":"1.36%","FiveDayReturnAfter":"0.07%","FiveDayReturnBefore":"-4.58%"},{"Ticker":"BAC","EffectiveDate":"2013-06-05","Type":"Dividend","Title":"The Firm pays dividend $0.01","DailyReturn":"-1.94%","FiveDayReturnAfter":"-1.73%","FiveDayReturnBefore":"0.07%"},{"Ticker":"BAC","EffectiveDate":"2013-05-20","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods downgrades BAC to Market Perform from Outperform.","DailyReturn":"0.59%","FiveDayReturnAfter":"-1.42%","FiveDayReturnBefore":"3.1%"},{"Ticker":"BAC","EffectiveDate":"2013-05-15","Type":"RatingNeutral","Title":"Deutsche Bank maintains BAC to Hold. Target Price is $13; previously $11.","DailyReturn":"0.74%","FiveDayReturnAfter":"0.74%","FiveDayReturnBefore":"3.35%"},{"Ticker":"BAC","EffectiveDate":"2013-04-23","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades BAC to Overweight from Equal-Weight. Target Price is $16; previously $13.","DailyReturn":"2.98%","FiveDayReturnAfter":"5.47%","FiveDayReturnBefore":"-2.19%"},{"Ticker":"BAC","EffectiveDate":"2013-04-18","Type":"RatingNeutral","Title":"Barclays maintains BAC to Equal-Weight. Target Price is $13; previously $10.","DailyReturn":"-2.22%","FiveDayReturnAfter":"5.08%","FiveDayReturnBefore":"-5.16%"},{"Ticker":"BAC","EffectiveDate":"2013-04-18","Type":"RatingNeutral","Title":"UBS maintains BAC to Neutral. Target Price is $12; previously $11.5.","DailyReturn":"-2.22%","FiveDayReturnAfter":"5.08%","FiveDayReturnBefore":"-5.16%"},{"Ticker":"BAC","EffectiveDate":"2013-04-18","Type":"RatingNeutral","Title":"Nomura maintains BAC to Neutral. Target Price is $12; previously $11.25.","DailyReturn":"-2.22%","FiveDayReturnAfter":"5.08%","FiveDayReturnBefore":"-5.16%"},{"Ticker":"BAC","EffectiveDate":"2013-04-17","Type":"EarningsMissRevenueBeat","Title":"Before market open, BAC reports 2013 Q1's earning $0.2 per share and revenue $23850MM. This misses analyst's estimated EPS $0.22, beats estimated revenue $23500MM.","DailyReturn":"-4.72%","FiveDayReturnAfter":"-1.72%","FiveDayReturnBefore":"0.24%"},{"Ticker":"BAC","EffectiveDate":"2013-03-15","Type":"RatingUpgrade","Title":"Scotiabank upgrades BAC to Sector Outperform from Sector Perform.","DailyReturn":"3.79%","FiveDayReturnAfter":"3.72%","FiveDayReturnBefore":"-1.23%"},{"Ticker":"BAC","EffectiveDate":"2013-03-08","Type":"RatingUpgrade","Title":"Edward Jones upgrades BAC to Buy from Hold.","DailyReturn":"-1.54%","FiveDayReturnAfter":"-1.23%","FiveDayReturnBefore":"8.77%"},{"Ticker":"BAC","EffectiveDate":"2013-02-27","Type":"Dividend","Title":"The Firm pays dividend $0.01","DailyReturn":"1.61%","FiveDayReturnAfter":"3.79%","FiveDayReturnBefore":"-9.09%"},{"Ticker":"BAC","EffectiveDate":"2013-02-07","Type":"RatingNeutral","Title":"Rafferty initiates coverage on BAC to Buy. Target Price is $14.75.","DailyReturn":"-0.75%","FiveDayReturnAfter":"1.99%","FiveDayReturnBefore":"4.72%"},{"Ticker":"BAC","EffectiveDate":"2013-01-17","Type":"EarningsBeatRevenueMiss","Title":"Before market open, BAC reports 2012 Q4's earning $0.03 per share and revenue $18660MM. This beats analyst's estimated EPS $0.02, misses estimated revenue $21030MM.","DailyReturn":"-4.24%","FiveDayReturnAfter":"-2.14%","FiveDayReturnBefore":"3.01%"},{"Ticker":"BAC","EffectiveDate":"2013-01-11","Type":"RatingNeutral","Title":"Sandler O'Neill downgrades BAC to Hold from Buy.","DailyReturn":"-1.27%","FiveDayReturnAfter":"-4.33%","FiveDayReturnBefore":"-1.51%"},{"Ticker":"BAC","EffectiveDate":"2013-01-10","Type":"RatingNeutral","Title":"UBS maintains BAC to Neutral. Target Price is $11.5; previously $9.5.","DailyReturn":"3.06%","FiveDayReturnAfter":"3.01%","FiveDayReturnBefore":"-5.11%"},{"Ticker":"BAC","EffectiveDate":"2013-01-09","Type":"RatingNeutral","Title":"Credit Suisse downgrades BAC to Neutral from Outperform. Target Price is $12; previously $11.","DailyReturn":"-4.59%","FiveDayReturnAfter":"-3.65%","FiveDayReturnBefore":"3.13%"},{"Ticker":"BAC","EffectiveDate":"2013-01-08","Type":"RatingNeutral","Title":"JP Morgan maintains BAC to Overweight. Target Price is $13.5; previously $13.","DailyReturn":"-0.9%","FiveDayReturnAfter":"-5.26%","FiveDayReturnBefore":"6.22%"},{"Ticker":"BAC","EffectiveDate":"2013-01-07","Type":"RatingNeutral","Title":"Goldman Sachs maintains BAC to Neutral. Target Price is $12.5; previously $12.","DailyReturn":"-0.16%","FiveDayReturnAfter":"-4.04%","FiveDayReturnBefore":"5.42%"},{"Ticker":"BAC","EffectiveDate":"2013-01-07","Type":"RatingNeutral","Title":"ISI Group maintains BAC to Buy. Target Price is $14; previously $13.","DailyReturn":"-0.16%","FiveDayReturnAfter":"-4.04%","FiveDayReturnBefore":"5.42%"},{"Ticker":"BAC","EffectiveDate":"2013-01-04","Type":"RatingNeutral","Title":"Deutsche Bank maintains BAC to Hold. Target Price is $11; previously $9.","DailyReturn":"1.25%","FiveDayReturnAfter":"-1.51%","FiveDayReturnBefore":"3.57%"},{"Ticker":"BAC","EffectiveDate":"2013-01-03","Type":"RatingNeutral","Title":"Citigroup maintains BAC to Neutral. Target Price is $12; previously $10.","DailyReturn":"-0.58%","FiveDayReturnAfter":"-5.11%","FiveDayReturnBefore":"6.7%"},{"Ticker":"BAC","EffectiveDate":"2013-01-03","Type":"RatingNeutral","Title":"Nomura maintains BAC to Neutral. Target Price is $11.25; previously $9.","DailyReturn":"-0.58%","FiveDayReturnAfter":"-5.11%","FiveDayReturnBefore":"6.7%"},{"Ticker":"BAC","EffectiveDate":"2012-12-07","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on BAC to Neutral. Target Price is $11.","DailyReturn":"1.72%","FiveDayReturnAfter":"0.76%","FiveDayReturnBefore":"6.31%"},{"Ticker":"BAC","EffectiveDate":"2012-12-05","Type":"Dividend","Title":"The Firm pays dividend $0.01","DailyReturn":"5.65%","FiveDayReturnAfter":"5.97%","FiveDayReturnBefore":"2.55%"},{"Ticker":"BAC","EffectiveDate":"2012-11-19","Type":"RatingUpgrade","Title":"Stifel Nicolaus upgrades BAC to Buy from Hold.","DailyReturn":"4.05%","FiveDayReturnAfter":"7.59%","FiveDayReturnBefore":"-3.34%"},{"Ticker":"BAC","EffectiveDate":"2012-11-08","Type":"RatingUpgrade","Title":"ISI Group upgrades BAC to Buy from Hold. Target Price is $12.","DailyReturn":"1.73%","FiveDayReturnAfter":"-2.63%","FiveDayReturnBefore":"-0.97%"},{"Ticker":"BAC","EffectiveDate":"2012-10-18","Type":"RatingNeutral","Title":"Sterne Agee maintains BAC to Neutral. Target Price is $10; previously $9.","DailyReturn":"0.31%","FiveDayReturnAfter":"-1.38%","FiveDayReturnBefore":"2.46%"},{"Ticker":"BAC","EffectiveDate":"2012-10-18","Type":"RatingNeutral","Title":"UBS maintains BAC to Neutral. Target Price is $9.5; previously $8.","DailyReturn":"0.31%","FiveDayReturnAfter":"-1.38%","FiveDayReturnBefore":"2.46%"},{"Ticker":"BAC","EffectiveDate":"2012-10-18","Type":"RatingNeutral","Title":"Nomura maintains BAC to Neutral. Target Price is $9; previously $8.","DailyReturn":"0.31%","FiveDayReturnAfter":"-1.38%","FiveDayReturnBefore":"2.46%"},{"Ticker":"BAC","EffectiveDate":"2012-10-17","Type":"EarningsBeatRevenueMiss","Title":"Before market open, BAC reports 2012 Q3's earning $0 per share and revenue $20400MM. This beats analyst's estimated EPS $-0.07, misses estimated revenue $21890MM.","DailyReturn":"-0.21%","FiveDayReturnAfter":"-1.06%","FiveDayReturnBefore":"2.67%"},{"Ticker":"BAC","EffectiveDate":"2012-10-17","Type":"RatingNeutral","Title":"ISI Group maintains BAC to Hold. Target Price is $10; previously $9.","DailyReturn":"-0.21%","FiveDayReturnAfter":"-1.06%","FiveDayReturnBefore":"2.67%"},{"Ticker":"BAC","EffectiveDate":"2012-10-02","Type":"RatingNeutral","Title":"Drexel Hamilton initiates coverage on BAC to Buy. Target Price is $11.","DailyReturn":"-0.33%","FiveDayReturnAfter":"3.5%","FiveDayReturnBefore":"-1.55%"},{"Ticker":"BAC","EffectiveDate":"2012-09-17","Type":"RatingNeutral","Title":"Citigroup maintains BAC to Neutral. Target Price is $10; previously $8.5.","DailyReturn":"-2.61%","FiveDayReturnAfter":"-4.71%","FiveDayReturnBefore":"8.17%"},{"Ticker":"BAC","EffectiveDate":"2012-09-05","Type":"Dividend","Title":"The Firm pays dividend $0.01","DailyReturn":"-0.5%","FiveDayReturnAfter":"12.23%","FiveDayReturnBefore":"-0.87%"},{"Ticker":"BAC","EffectiveDate":"2012-07-18","Type":"RatingNeutral","Title":"ISI Group maintains BAC to Hold. Target Price is $8; previously $9.","DailyReturn":"-4.92%","FiveDayReturnAfter":"-11.77%","FiveDayReturnBefore":"5.71%"},{"Ticker":"BAC","EffectiveDate":"2012-07-18","Type":"EarningsBeatRevenueMiss","Title":"Before market open, BAC reports 2012 Q2's earning $0.19 per share and revenue $22200MM. This beats analyst's estimated EPS $0.14, misses estimated revenue $22870MM.","DailyReturn":"-4.92%","FiveDayReturnAfter":"-11.77%","FiveDayReturnBefore":"5.71%"},{"Ticker":"BAC","EffectiveDate":"2012-07-11","Type":"RatingNeutral","Title":"Bernstein maintains BAC to Market Perform. Target Price is $9; previously $9.5.","DailyReturn":"2%","FiveDayReturnAfter":"5.71%","FiveDayReturnBefore":"-7.34%"},{"Ticker":"BAC","EffectiveDate":"2012-06-04","Type":"RatingNeutral","Title":"UBS maintains BAC to Neutral. Target Price is $7.5; previously $10.","DailyReturn":"-1.7%","FiveDayReturnAfter":"7.41%","FiveDayReturnBefore":"-1.56%"},{"Ticker":"BAC","EffectiveDate":"2012-05-30","Type":"Dividend","Title":"The Firm pays dividend $0.01","DailyReturn":"-3.09%","FiveDayReturnAfter":"-4.54%","FiveDayReturnBefore":"8.55%"},{"Ticker":"BAC","EffectiveDate":"2012-05-22","Type":"RatingNeutral","Title":"Sterne Agee maintains BAC to Neutral. Target Price is $8; previously $10.","DailyReturn":"2.19%","FiveDayReturnAfter":"8.55%","FiveDayReturnBefore":"-7.33%"},{"Ticker":"BAC","EffectiveDate":"2012-04-20","Type":"RatingNeutral","Title":"Citigroup maintains BAC to Neutral. Target Price is $9; previously $8.5.","DailyReturn":"-4.67%","FiveDayReturnAfter":"-5.87%","FiveDayReturnBefore":"-4.46%"},{"Ticker":"BAC","EffectiveDate":"2012-04-11","Type":"RatingUpgrade","Title":"Guggenheim upgrades BAC to Buy from Neutral. Target Price is $11.","DailyReturn":"3.74%","FiveDayReturnAfter":"4.35%","FiveDayReturnBefore":"-12.53%"},{"Ticker":"BAC","EffectiveDate":"2012-04-10","Type":"RatingNeutral","Title":"JP Morgan maintains BAC to Overweight. Target Price is $11.5; previously $10.5.","DailyReturn":"-4.36%","FiveDayReturnAfter":"-1.58%","FiveDayReturnBefore":"-6.92%"},{"Ticker":"BAC","EffectiveDate":"2012-04-02","Type":"RatingNeutral","Title":"UBS maintains BAC to Neutral. Target Price is $10; previously $8.","DailyReturn":"1.14%","FiveDayReturnAfter":"-6.92%","FiveDayReturnBefore":"-2.88%"},{"Ticker":"BAC","EffectiveDate":"2012-03-30","Type":"RatingNeutral","Title":"Deutsche Bank maintains BAC to Hold. Target Price is $9; previously $7.5.","DailyReturn":"0.41%","FiveDayReturnAfter":"-3.19%","FiveDayReturnBefore":"-0.73%"},{"Ticker":"BAC","EffectiveDate":"2012-03-19","Type":"RatingNeutral","Title":"Morgan Stanley maintains BAC to Equal-Weight. Target Price is $9; previously $7.","DailyReturn":"-2.75%","FiveDayReturnAfter":"0.5%","FiveDayReturnBefore":"19.67%"},{"Ticker":"BAC","EffectiveDate":"2012-02-29","Type":"Dividend","Title":"The Firm pays dividend $0.01","DailyReturn":"-1.72%","FiveDayReturnAfter":"-5.05%","FiveDayReturnBefore":"0.12%"},{"Ticker":"BAC","EffectiveDate":"2012-02-27","Type":"RatingNeutral","Title":"UBS maintains BAC to Neutral. Target Price is $8; previously $7.","DailyReturn":"2.03%","FiveDayReturnAfter":"3.24%","FiveDayReturnBefore":"-2.63%"},{"Ticker":"BAC","EffectiveDate":"2012-02-14","Type":"RatingNeutral","Title":"Citigroup downgrades BAC to Neutral from Buy. Target Price is $8.5; previously $8.","DailyReturn":"-3.27%","FiveDayReturnAfter":"-1.71%","FiveDayReturnBefore":"3.45%"}];